Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning

por Tordai, Attila, Bors, Andras, Kiss, Katalin Piroska, Balassa, Katalin, Andrikovics, Hajnalka, Batai, Arpad, Szilvasi, Aniko, Rajczy, Katalin, Inotai, Dora, Torbagyi, Eva, Lengyel, Lilla, Barta, Aniko, Remenyi, Peter, Masszi, Tamas
Publicado 2019